Patent · US Active

RNA interference in skin indications

US9938530B2 · kind B2 · utility

23Cited by

166References

19Claims

0Family size

Assignee

RXi Pharmaceuticals Corporation · US

Inventors

Anastasia Khvorova · Boulder, US
William Salomon · Worcester, US
Joanne Kamens · Newton, US
Dmitry Samarsky · Berlin, DE
Tod M. Woolf · Sudbury, US
Pamela Pavco · Longmont, US
James Cardia · Franklin, US

Key dates

Filing date	Feb 11, 2016
Grant date	Apr 10, 2018
Priority date	—
Expiry date	Feb 11, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.